資本剰余金、研究開発費 - 化成品事業、少数株主持分
- 【期間】
| 年度 | 資本剰余金 | 研究開発費 - 化成品事業 | 少数株主持分 |
|---|
| 2007/03 | 81.2億 | | - | | 6.05億 | |
| 2008/03 | 81.2億 | -0% | - | | 4.68億 | -22.6% |
| 2009/03 | 81.2億 | ±0% | - | | 3.78億 | -19.2% |
| 2010/03 | 81.2億 | ±0% | - | | 4.31億 | +14% |
| 2011/03 | 81.2億 | ±0% | - | | 8.33億 | +93.3% |
| 2012/03 | 81.2億 | ±0% | - | | 13.5億 | +61.5% |
| 2013/03 | 81.2億 | ±0% | - | | 16.9億 | +25.4% |
| 2014/03 | 81.2億 | ±0% | - | | 17.7億 | +4.7% |
| 2015/03 | 81.2億 | ±0% | - | | 22.6億 | +28.1% |
| 2016/03 | 81.2億 | ±0% | - | | - | |
| 2017/03 | 81.2億 | ±0% | - | | - | |
| 2018/03 | 81.1億 | -0.1% | - | | - | |
| 2019/03 | 81.1億 | ±0% | 42.6億 | | - | |
| 2020/03 | 81.1億 | ±0% | 45.1億 | +6% | - | |
| 2021/03 | 81.1億 | ±0% | 45億 | -0.3% | - | |
| 2022/03 | 81.1億 | ±0% | 44.9億 | -0.2% | - | |
| 2023/03 | 81.1億 | ±0% | 48.5億 | +8.1% | - | |
